IOVANCE BIOTHERAPEUTICS
LIVE

Serial Number

90398613

Owner

Iovance Biotherapeutics, Inc.

Attorney

Carla B. Oakley

First Use Date

Feb 16, 2024

Filing Date

Dec 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IOVANCE BIOTHERAPEUTICS Trademark

Serial Number: 90398613 • Registration: 7922016

IOVANCE BIOTHERAPEUTICS is a trademark filed by Iovance Biotherapeutics, Inc. on December 21, 2020. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Iovance Biotherapeutics, Inc. (3 trademarks)

San Carlos, CA 94070

Entity Type: 03

Trademark Details

Filing Date

December 21, 2020

Registration Date

August 26, 2025

First Use Anywhere

February 16, 2024

First Use in Commerce

February 16, 2024

Published for Opposition

July 20, 2021

Goods & Services

providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, and healthcare; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments

telecommunications services, namely, transmission of data and graphics between healthcare providers via global and local computer networks in the fields of telehealth and telemedicine

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 7, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 7, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 7, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 4, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 4, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2025 CRFA
ASSIGNED TO LIE
Jun 16, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 10, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 10, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 10, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 10, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 19, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 19, 2024 AITU
USE AMENDMENT FILED
Sep 16, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 16, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2024 EXRA
SOU EXTENSION 5 GRANTED
Mar 13, 2024 EX5G
SOU EXTENSION 5 FILED
Mar 13, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2023 EXRA
SOU EXTENSION 4 GRANTED
Aug 14, 2023 EX4G
SOU EXTENSION 4 FILED
Aug 14, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 17, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 17, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2022 EXRA
SOU EXTENSION 2 GRANTED
Sep 1, 2022 EX2G
SOU EXTENSION 2 FILED
Sep 1, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 1, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 27, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 27, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 27, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 14, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 16, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 16, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 16, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 16, 2021 CNEA
ASSIGNED TO EXAMINER
Jun 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2021 NWOS
NEW APPLICATION ENTERED
Dec 24, 2020 NWAP